Coronavirus Makes Biotech ETFs Red Hot
Zacks Investment Research | Apr 21, 2020 02:00AM ET
The biotech space of the broader healthcare sector is currently the hottest of all segments buoyed by the COVID-19 pandemic. This is especially true as the rapidly spreading virus, which has now infected more than 2.4 million people globally and claimed 166,000 lives, has raised the need to diagnose the disease, leading to strong demand for testing kits.
The epidemic has also opened new doors for biotech companies, whether big or small, to discover and create vaccines and treatments related to the COVID-19 pandemic.
Testing Kits
Many companies have quickly developed tests receiving emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA). Abbott Labs Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.